AMERICAN INTERNATIONAL GROUP, INC. - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,945
+2.2%
7,102
+48.8%
0.00%
Q2 2023$21,474
-42.0%
4,772
-11.2%
0.00%
Q1 2022$37,000
-48.6%
5,373
-6.6%
0.00%
Q4 2021$72,000
-61.1%
5,751
-2.9%
0.00%
-100.0%
Q3 2021$185,000
+6.3%
5,923
-2.3%
0.00%0.0%
Q2 2021$174,000
-30.4%
6,064
+5.0%
0.00%0.0%
Q1 2021$250,000
-34.6%
5,776
+8.2%
0.00%0.0%
Q4 2020$382,0005,3380.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$124,994,0001.61%
Baker Brothers Advisors 10,123,824$126,042,0000.61%
Pinz Capital Management, LP 43,800$545,0000.21%
HHLR ADVISORS, LTD. 583,333$7,262,0000.11%
Rock Springs Capital Management LP 368,959$4,594,0000.11%
Nan Fung Group Holdings Ltd 20,350$253,0000.08%
Virtus ETF Advisers LLC 13,815$172,0000.06%
PDT Partners, LLC 35,907$447,0000.03%
Jump Financial, LLC 36,900$459,0000.03%
Parkwood LLC 12,667$158,0000.03%
View complete list of PRELUDE THERAPEUTICS INC shareholders